Atlas Trials

Influence of Exceptional Patient Characteristics on Everolimus Exposure

Clinical trial NCT01948960 · COMPLETED

Trial details

NCT number
NCT01948960
Sponsor
Radboud University Medical Center
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Breast Neoplasms
Start date
2013-08-01
Primary completion
2018-01-15
Enrollment
56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.